DE3514724C2 - - Google Patents

Info

Publication number
DE3514724C2
DE3514724C2 DE19853514724 DE3514724A DE3514724C2 DE 3514724 C2 DE3514724 C2 DE 3514724C2 DE 19853514724 DE19853514724 DE 19853514724 DE 3514724 A DE3514724 A DE 3514724A DE 3514724 C2 DE3514724 C2 DE 3514724C2
Authority
DE
Germany
Prior art keywords
vitamin
ointment
testosterone
ointment base
progesterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19853514724
Other languages
German (de)
English (en)
Other versions
DE3514724A1 (de
Inventor
Albin F. Dr. 4200 Oberhausen De Jereb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19853514724 priority Critical patent/DE3514724A1/de
Publication of DE3514724A1 publication Critical patent/DE3514724A1/de
Application granted granted Critical
Publication of DE3514724C2 publication Critical patent/DE3514724C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE19853514724 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen Granted DE3514724A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19853514724 DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853514724 DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Publications (2)

Publication Number Publication Date
DE3514724A1 DE3514724A1 (de) 1986-10-30
DE3514724C2 true DE3514724C2 (enExample) 1989-10-26

Family

ID=6268943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853514724 Granted DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Country Status (1)

Country Link
DE (1) DE3514724A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38813E1 (en) 1990-01-29 2005-10-04 Johnson & Johnson Consumer Companies, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
EP0549592B2 (en) † 1991-06-27 2008-10-22 Johnson & Johnson Consumer Companies, Inc. Stabilized retinoid-containing skin care compositions
CN109700763A (zh) * 2011-01-26 2019-05-03 阿勒根公司 用于治疗眼科病症的雄性激素组合物

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684297B1 (fr) * 1991-11-28 1995-06-09 Bfb Utilisation d'un acide amine soufre pour la preparation d'un medicament destine au traitement de l'eczema.
US5510391A (en) * 1993-10-22 1996-04-23 Mayapple Holdings, Llc Method of treating blood vessel disorders of the skin using vitamin K
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
UA10208A (uk) * 1994-08-03 1996-12-25 Жанна Прокопівна Гудзенко Дерматологічний косметичний засіб
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
FR2738743B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation de l'acide ascorbique comme actif pour le traitement de la seborrhee dans une composition cosmetique et/ou dermatologique
CN1054741C (zh) * 1995-10-09 2000-07-26 康孟喆 眼用医药组合物
EP0862916B1 (en) * 1995-11-20 2003-03-05 Kiyoshi Kita topical use of vitamin D for the treatment of eye disorders
WO1999022728A1 (en) * 1997-10-31 1999-05-14 Arch Development Corporation Methods and compositions for regulation of 5-alpha reductase activity
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
CN1168449C (zh) * 2002-12-23 2004-09-29 梁有国 抗人乳头瘤病毒感染的药物
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US6833141B1 (en) * 2003-07-11 2004-12-21 Joseph L. Owades Method of treating pruritis and composition thereof
EP2494965A3 (en) 2005-04-15 2013-01-02 The Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38813E1 (en) 1990-01-29 2005-10-04 Johnson & Johnson Consumer Companies, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
EP0549592B2 (en) † 1991-06-27 2008-10-22 Johnson & Johnson Consumer Companies, Inc. Stabilized retinoid-containing skin care compositions
CN109700763A (zh) * 2011-01-26 2019-05-03 阿勒根公司 用于治疗眼科病症的雄性激素组合物

Also Published As

Publication number Publication date
DE3514724A1 (de) 1986-10-30

Similar Documents

Publication Publication Date Title
DE3514724C2 (enExample)
EP0224837B1 (de) Hautwirksame Pharmaka mit Liposomen als Wirkstoffträger
EP0152106B1 (de) Rheumamittel
DE60217900T2 (de) Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung
DE2802924C2 (de) Arzneimittel zur Behandlung von Akne
DE2818553A1 (de) Zusammensetzung zur behandlung von proliferativen hautkrankheiten
EP0343694A2 (de) Mittel zur Behandlung und zum Schutz der Haut
DE2046119A1 (de) Mitte) zur Behandlung der Akne
DE2240187A1 (de) Salbe
DE60004786T2 (de) Verfahren und zusammensetzung zur behandlung von akne
DE3786714T2 (de) Therapeutisches Mittel für Hautgeschwüre.
EP1131063B1 (de) Hyperforin-salbe oder -creme
DE69927260T2 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
EP0151987B1 (de) Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
DE60316724T2 (de) Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasolpropionat
EP0198172B1 (de) Pharmazeutische Zubereitung
DE4022815A1 (de) Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE19681207B4 (de) Therapeutische Verwendung von Rubidiumionen und Zubereitungen
DE4300969C2 (de) Verwendung von Malotilat zum Beschleunigen der Wundheilung bei Hautverbrennungen
DE69205307T2 (de) Vorrichtung zum Behandeln von Akupunkturpunkten mittels elektrischen Feldern und Medikamentenionen.
DE4315866C1 (de) Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren
DE68902792T2 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
DE68905788T2 (de) Lokal anzuwendende arzneizubereitungen enthaltend ticlopidine.
DE1922192C2 (de) Zusammensetzungen zur Behandlung von trophischen Störungen der Haut und Verfahren zu ihrer Herstellung
DE3633651C2 (enExample)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee